AGIO
Agios Pharmaceuticals Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Agios Pharmaceuticals Inc is focused on the research and development of cellular and molecular therapies for the treatment of rare genetic diseases and cancer.
Agios Pharmaceuticals Inc
AGIO
Agios Pharmaceuticals Inc is focused on the research and development of cellular and molecular therapies for the treatment of rare genetic diseases and cancer.
Price history of Agios Pharmaceuticals Inc
Price history of Agios Pharmaceuticals Inc
Performance & Momentum
Strategic Analysis
Agios Pharmaceuticals Inc • 2026
Agios Pharmaceuticals is a U.S. biotech company specializing in targeted therapies for rare genetic diseases and oncology, with a focus on research and development of molecules with high medical value. Its equity appeal rests on a demanding scientific niche, where clinical and regulatory success can create strong differentiation, but visibility remains dependent on pipeline execution.
- Niche positioning in rare indications and oncology, with high value potential in the event of clinical success
- Expertise in medical research and the development of targeted therapies, which strengthens scientific credibility
- Overall positive momentum, suggesting renewed market interest despite persistent volatility
- Heavy dependence on clinical and regulatory outcomes, with the binary failure risk typical of biotech companies
- Mixed long-term share-price history, showing that value creation remains uneven
Momentum appears constructive, with a favorable trend over the past year and on a more recent multi-year horizon, even if the near-term phase remains more choppy. For investors, this reflects a market that is increasingly crediting the quality of the pipeline and the scientific potential, while still assigning a high risk premium due to execution uncertainty.
Similar stocks to Agios Pharmaceuticals Inc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
